Status:
RECRUITING
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
Lead Sponsor:
Stony Brook University
Conditions:
Postpartum Hemorrhage
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
To determine the effectiveness of using two medications simultaneously versus one medication, as is standard of care, in preventing early postpartum hemorrhage. There have been studies that looked at...
Detailed Description
Postpartum hemorrhage (PPH) is the leading cause of maternal morbidity and mortality in the world, accounting for a quarter of all maternal deaths globally. Most cases of PPH can be attributed to uter...
Eligibility Criteria
Inclusion
- \- All women 18 years and older admitted to delivery at Stony Brook University hospital who agree to participate in the study
Exclusion
- Women under 18 years old
- Women with known coagulation disorders
- Women with planned cesarean hysterectomy
- Women with known placental accreta spectrum disorders
- Women with known allergy to prostaglandins
Key Trial Info
Start Date :
January 27 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
1358 Patients enrolled
Trial Details
Trial ID
NCT05245227
Start Date
January 27 2025
End Date
January 1 2027
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stony Brook University
Stony Brook, New York, United States, 11794